| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 47.911 | 49.683 | 55.307 | 62.658 | 87.417 | 88.917 | 91.104 | 113.128 | 126.559 | 131.026 |
| Total Income - EUR | 47.912 | 49.683 | 55.307 | 62.658 | 87.418 | 88.918 | 91.104 | 113.128 | 126.560 | 131.027 |
| Total Expenses - EUR | 44.017 | 38.656 | 40.907 | 40.432 | 43.923 | 46.564 | 44.335 | 40.042 | 32.960 | 37.096 |
| Gross Profit/Loss - EUR | 3.894 | 11.027 | 14.401 | 22.226 | 43.496 | 42.354 | 46.770 | 73.087 | 93.600 | 93.931 |
| Net Profit/Loss - EUR | 2.457 | 10.530 | 13.848 | 21.600 | 42.621 | 41.465 | 45.859 | 71.955 | 92.334 | 90.000 |
| Employees | 3 | 3 | 3 | 0 | 3 | 2 | 2 | 2 | 1 | 1 |
Check the financial reports for the company - Dasimed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.688 | 1.188 | 993 | 802 | 621 | 2.144 | 1.681 | 3.821 | 2.984 | 3.440 |
| Current Assets | 20.448 | 20.077 | 15.353 | 26.799 | 52.349 | 51.031 | 47.689 | 12.224 | 110.255 | 90.859 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 132 | 0 | 147 |
| Receivables | 18.446 | 15.814 | 3.440 | 22.298 | 46.592 | 47.270 | 43.358 | 6.303 | 100.550 | 74.039 |
| Cash | 2.001 | 4.262 | 11.913 | 4.500 | 5.756 | 3.761 | 4.331 | 5.789 | 9.705 | 16.673 |
| Shareholders Funds | 19.430 | 3.264 | 13.991 | 25.054 | 49.278 | 50.012 | 46.339 | 14.083 | 106.374 | 90.126 |
| Social Capital | 56 | 56 | 55 | 54 | 53 | 52 | 51 | 51 | 51 | 50 |
| Debts | 2.705 | 18.001 | 2.354 | 2.546 | 3.691 | 3.163 | 3.032 | 1.962 | 6.865 | 4.172 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dasimed Srl